MICHELLE SHAUGER: Open Payments
NPI 1740334176 · ANN ARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 11 payments from 6 companies in 2025. Trend: 2023 $896 · 2024 $725 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $194 |
| ABBVIE INC. | 2 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $127 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $16 |
Products named: ABILIFY MAINTENA, VRAYLAR, CAPLYTA, INGREZZA, REXULTI, Qelbree, ARISTADA.
Industry payments across MI — which companies pay providers there.
